Jean-Sébastien Delisle

14PUBLICATIONS
44CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 30, 2026
Rapidly Expanded EBV-Specific T Cells for the Treatment of Refractory EBV Reactivation and EBV-Related Lymphoproliferative Disorders.

Lorne Schweitzer, Stéphanie Thiant, Cynthia Thérien

|Jun 15, 2025
Blockade of colon cancer metastasis via single and double silencing of PCSK7/PCSK9: enhanced T cells cytotoxicity in mouse and human.

Chloé Porcheron, Mailys Le Devehat, Anna Roubtsova

|May 06, 2025
Virus-Specific T-Cell Therapy for Prophylaxis and Treatment of Cytomegalovirus Infections After Transplantation: a Scoping Review.

Jollee S T Fung, Robert C Wright, Dilpreet K Bharaj

|Apr 20, 2025
MARC, a novel modular chimeric antigen receptor, improves T cell-based cancer immunotherapies by preventing early T cell exhaustion and enhancing persistence.

Margaux Tual, Angélique Bellemare-Pelletier, Susan Moore

|Mar 26, 2025
Enhancing CAR-T Efficacy in Large B-Cell Lymphoma with Radiation Bridging Therapy: A Real-World Single-Center Experience.

Eva Laverdure, Luigina Mollica, Imran Ahmad

|Jan 29, 2025
Approach to autologous stem cell transplantation in a patient with severe cold agglutinin disease, a case report.

Mathias Castonguay, Léa Bernard, Marylène Corriveau

Pageof 3